No Data
No Data
A. G. P. Initiates Evogene(EVGN.US) With Buy Rating, Announces Target Price $2.25
A. G. P. analyst Scott Henry initiates coverage on $Evogene(EVGN.US)$ with a buy rating, and sets the target price at $2.25.According to TipRanks data, the analyst has a success rate of 40.0% and a to
Evogene Subsidiary Casterra Ag Expands Into Africa With $440K Castor Seed Order
Casterra Ag Ltd., a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), is a provider of an integrated solution for industrial-scale cultivation of castor plants based on its elite castor seed vari
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country
Current castor seed production is expected to support the supply of the new order in 2024, valued at ~ $440K REHOVOT, Israel, June 25, 2024 /PRNewswire/ -- Casterra Ag Ltd., a subsidiary of Evogene L
Evogene Innovates With AI in Life-Sciences
Earnings Call Summary | Evogene(EVGN.US) Q1 2024 Earnings Conference
The following is a summary of the Evogene Ltd. (EVGN) Q1 2024 Earnings Call Transcript:Financial Performance:Evogene reported total revenue of approximately $4.2 million in Q1 2024, a significant incr
Biomica Presents Positive Clinical Data Update From Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma
Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....